<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03326089</url>
  </required_header>
  <id_info>
    <org_study_id>CorfuGH569</org_study_id>
    <nct_id>NCT03326089</nct_id>
  </id_info>
  <brief_title>Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis</brief_title>
  <official_title>Short and Long-term Effects of Oxygen Supplemented Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Corfu General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corfu General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an interventional double-blind randomized controlled trial, to investigate the short
      and long-term effects of a supervised exercise training program in patients with IPF,
      depending on alternate patterns of oxygen supplementation during PR.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that PR service with supplemented oxygen supply regardless of
      hypoxemia may have significantly better short-term effects in patients with IPF. The study
      will take place in Corfu General Hospital, by the Departments of Pulmonary Medicine and
      Physiotherapy and Rehabilitation, respectively. Study participants will be divided in two
      equal arms 1:1 in a double-blind manner. One of the investigators blinded to their clinical
      data will assign each participant to PR service either i) with constant supplementary oxygen
      supply FiO2 50% regardless of saturation status Group A) or ii) without oxygen supply unless
      upon resting or exercise induced hypoxemia (saturation &lt;88%) (Group B).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>participants are blindly randomized to receive oxygen or not during rehabilitation.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>6 Minute Walk Test Distance (6MWTD) (meters)</measure>
    <time_frame>2 months</time_frame>
    <description>Statistically significant short term effect on exercise capacity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Saint-George Respiratory Questionnaire Idiopathic Pulmonary Fibrosis Version (SGRQ-I) (units on scale)</measure>
    <time_frame>2 months</time_frame>
    <description>Statistically significant short term effect on health related quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS) (units on scale)</measure>
    <time_frame>2 months</time_frame>
    <description>Statistically significant short term effect on health related quality of life</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>6 Minute Walk Test Distance (6MWTD) (meters)</measure>
    <time_frame>12 months</time_frame>
    <description>Statistically significant long term effect on exercise capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saint-George Respiratory Questionnaire Idiopathic Pulmonary Fibrosis Version (SGRQ-I) (units on scale)</measure>
    <time_frame>12 months</time_frame>
    <description>Statistically significant long term effect on health related quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Anxiety and Depression Scale (HADS) (units on scale)</measure>
    <time_frame>12 months</time_frame>
    <description>Statistically significant long term effect on health related quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Idiopathic Pulmonary Fibrosis</condition>
  <arm_group>
    <arm_group_label>High flow oxygen supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulmonary rehabilitation with constant high flow supplementary oxygen supply FiO2 50% for 2 months (Group A).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Oxygen supplementation upon hypoxemia</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Pulmonary rehabilitation without oxygen supply unless upon resting or exercise induced hypoxemia for 2 months (Group B).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary rehabilitation</intervention_name>
    <description>Endurance training for 30 minutes, 3 times/week for 2 months followed by resistance training</description>
    <arm_group_label>High flow oxygen supplementation</arm_group_label>
    <arm_group_label>Oxygen supplementation upon hypoxemia</arm_group_label>
    <other_name>oxygen supplementation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of IPF based on current established criteria

          -  no exacerbation previous 3 months

          -  no participation in such program previous 3 months.

          -  If on treatment with pirfenidone or nintedanib, this will be recorded and patient
             should be on treatment for at least 3-6 months to achieve stable state.

        Exclusion Criteria:

        - concomitant diagnosis of congestive heart failure and lung cancer.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefanos Patsiris</last_name>
    <role>Study Director</role>
    <affiliation>Physiotherapy Director</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ilias Papanikolaou</last_name>
    <phone>00306974305925</phone>
    <email>icpapanikolaou@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Corfu General Hospital</name>
      <address>
        <city>Corfu</city>
        <zip>49100</zip>
        <country>Greece</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ilias Papanikolaou</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2017</study_first_submitted>
  <study_first_submitted_qc>October 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2017</study_first_posted>
  <last_update_submitted>October 29, 2017</last_update_submitted>
  <last_update_submitted_qc>October 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Corfu General Hospital</investigator_affiliation>
    <investigator_full_name>Ilias Papanikolaou</investigator_full_name>
    <investigator_title>Consultant Pulmonary Physician</investigator_title>
  </responsible_party>
  <keyword>pulmonary rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
    <mesh_term>Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Pulmonary Fibrosis</mesh_term>
    <mesh_term>Idiopathic Interstitial Pneumonias</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Everything will be published in time.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

